Fig. 5From: Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myelomaSurvival analysis of all patients with available Sβ2M, ALB and LDH information. a Kaplan-Meier curves for patients with higher Sβ2M level (≥3.5 mg/L). b Kaplan-Meier curves for patients with lower Sβ2M level (<3.5 mg/L). c Kaplan-Meier curves for patients with higher ALB (≥35 g/L). d Kaplan-Meier curves for patients with lower ALB (<35 g/L). e Kaplan-Meier curves for patients with higher LDH (>190 U/L). f Kaplan-Meier curves for patients with lower LDH (≤190 U/L)Back to article page